Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205657894/composite

$

8.40

Change

-0.07 -0.83%

Volume

Volume 62,856

May 20, 2022, 7:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Previous close

$ 8.31

$ 8.47

Change

+0.16 +1.93%

Day low

Day high

$8.19

$8.52

Open
Open: 8.40

52 week low

52 week high

$7.23

$11.55

Open

Market cap

$9.21B

Average volume

9.01M

P/E ratio

N/A

Rev. per Employee

$413,885

EPS

-0.56

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Teva Pharmaceutical upgraded to neutral from underperform at BofA Securities

    9:36 a.m. May 17, 2022

    - Tomi Kilgore

  2. Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

    10:06 a.m. May 10, 2022

    - Barron's Online

  3. Teva CEO Sees a Final Opioid Settlement Coming This Year

    4:58 p.m. May 3, 2022

    - Barron's Online

  4. Teva now sees full-year revenue of $15.4 bln to $16.0 bln vs. prior guidance of $15.6 bln to $16.2 bln

    7:19 a.m. May 3, 2022

    - Ciara Linnane

  5. Teva now sees full-year EPS of $2.40 to $2.60, unchanged vs. prior guidance

    7:20 a.m. May 3, 2022

    - Ciara Linnane

  6. Teva lowers full-year revenue guidance

    7:19 a.m. May 3, 2022

    - Ciara Linnane

  7. Teva Q1 adj. EPS 55 cents; FactSet consensus 53 cents

    7:17 a.m. May 3, 2022

    - Ciara Linnane

  8. Teva Q1 revenue $3.661 bln, down 8%; FactSet consensus $3.598 bln

    7:18 a.m. May 3, 2022

    - Ciara Linnane

  9. Teva Q1 loss per share 86 cents vs. EPS 7 cents a year ago

    7:17 a.m. May 3, 2022

    - Ciara Linnane

  10. Teva, Others to Pay Millions in Florida Opioid Settlements

    12:43 p.m. March 30, 2022

    - Barron's Online

  11. Teva Pharmaceutical upgraded to outperform at Bernstein

    1:38 p.m. March 25, 2022

    - Tomi Kilgore

  12. Teva Pharmaceutical sees 2022 revneue $15.6 bln-$16.2 bln; FactSet consensus $16.1 bln

    8:10 a.m. Feb. 9, 2022

    - Tomi Kilgore

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. Teva wins U.K. approval for Lucentis biosimilar

    10:19 a.m. May 17, 2022

    - Seeking Alpha

  2. Teva raised to Neutral at BofA citing a near-term opioid deal

    9:28 a.m. May 17, 2022

    - Seeking Alpha

  3. Teva's Q1 Results: Is the Stock About to Crash?

    4:35 p.m. May 5, 2022

    - Motley Fool

  4. 10-Q: TEVA PHARMACEUTICAL INDUSTRIES LTD

    4:10 p.m. May 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Teva slips as forex impact prompts guidance cut

    8:05 a.m. May 3, 2022

    - Seeking Alpha

  6. Notable earnings before Tuesday's open

    10:26 a.m. May 2, 2022

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. When Teva Pharmaceutical (TEVA) Moves Investors should Listen

    2:00 p.m. May 11, 2022

    - Stock Traders Daily

  2. Teva Reports First Quarter 2022 Financial Results

    7:00 a.m. May 3, 2022

    - BusinessWire - BZX

  3. Trend Tracker for Teva Pharmaceutical TEVA

    10:23 p.m. May 1, 2022

    - Stock Traders Daily

  4. Teva Pharmaceutical TEVA Trading Signals

    5:44 a.m. April 22, 2022

    - Stock Traders Daily

  5. Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM

    5:15 p.m. April 19, 2022

    - BusinessWire - BZX

  6. Wednesday's ETF with Unusual Volume: EIS

    12:05 p.m. April 13, 2022

    - MarketNewsVideo.com

  7. Trading Teva Pharmaceutical TEVA With Integrated Risk Controls

    12:21 p.m. April 12, 2022

    - Stock Traders Daily

  8. Teva Pharmaceutical TEVA Trading Advice

    6:10 p.m. April 2, 2022

    - Stock Traders Daily

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.